Cathay Historical Income Statement

688065 Stock   45.01  0.36  0.79%   
Historical analysis of Cathay Biotech income statement accounts such as Net Interest Income of 134.7 M, Interest Income of 156.9 M or Interest Expense of 19.7 M can show how well Cathay Biotech performed in making a profits. Evaluating Cathay Biotech income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Cathay Biotech's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Cathay Biotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cathay Biotech is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Cathay Income Statement Analysis

Cathay Biotech Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cathay Biotech shareholders. The income statement also shows Cathay investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Cathay Biotech Income Statement Chart

At present, Cathay Biotech's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 2.3 B, whereas Net Interest Income is forecasted to decline to about 134.7 M.

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Total Revenue

Total revenue comprises all receipts Cathay Biotech generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Cost Of Revenue

Cost of Revenue is found on Cathay Biotech income statement and represents the costs associated with goods and services Cathay Biotech provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most accounts from Cathay Biotech's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Cathay Biotech current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, Cathay Biotech's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 2.3 B, whereas Net Interest Income is forecasted to decline to about 134.7 M.
 2021 2022 2023 2024 (projected)
Interest Expense16.3M20.0M32.2M19.7M
Interest Income213.3M236.8M219.8M156.9M

Cathay Biotech income statement Correlations

-0.24-0.26-0.440.420.120.90.820.5-0.41-0.38-0.14-0.12-0.50.830.920.25
-0.241.00.44-0.720.79-0.49-0.740.610.930.930.920.90.90.320.11-0.97
-0.261.00.49-0.690.81-0.49-0.760.580.950.950.930.910.920.290.08-0.98
-0.440.440.490.110.58-0.29-0.59-0.090.660.710.670.690.67-0.21-0.37-0.5
0.42-0.72-0.690.11-0.260.750.67-0.4-0.56-0.53-0.43-0.38-0.570.00.120.65
0.120.790.810.58-0.26-0.08-0.420.760.780.760.950.960.710.480.29-0.85
0.9-0.49-0.49-0.290.75-0.080.890.14-0.54-0.51-0.32-0.28-0.60.620.730.48
0.82-0.74-0.76-0.590.67-0.420.89-0.03-0.85-0.81-0.65-0.63-0.890.380.580.76
0.50.610.58-0.09-0.40.760.14-0.030.410.360.620.620.320.750.65-0.64
-0.410.930.950.66-0.560.78-0.54-0.850.410.950.920.920.990.11-0.12-0.96
-0.380.930.950.71-0.530.76-0.51-0.810.360.950.930.910.930.15-0.07-0.9
-0.140.920.930.67-0.430.95-0.32-0.650.620.920.931.00.870.330.11-0.94
-0.120.90.910.69-0.380.96-0.28-0.630.620.920.911.00.870.330.12-0.94
-0.50.90.920.67-0.570.71-0.6-0.890.320.990.930.870.870.02-0.21-0.93
0.830.320.29-0.210.00.480.620.380.750.110.150.330.330.020.97-0.27
0.920.110.08-0.370.120.290.730.580.65-0.12-0.070.110.12-0.210.97-0.05
0.25-0.97-0.98-0.50.65-0.850.480.76-0.64-0.96-0.9-0.94-0.94-0.93-0.27-0.05
Click cells to compare fundamentals

Cathay Biotech Account Relationship Matchups

Currently Active Assets on Macroaxis

Other Information on Investing in Cathay Stock

Cathay Biotech Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cathay Biotech shareholders. The income statement also shows Cathay investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).